18-month Project Receives Funding to Support Curriculum to Train Educators

Santa Clara University (SCU) and Biocom California Institute (BCI), the workforce arm of Biocom California, have launched a strategic partnership designed to help community college students become critical innovators in the fast-growing biomanufacturing field.

The new BioCAD Data Programming for Biomanufacturing Scale-up project, also supported by Genentech and Merck, was funded by a $500,000 award from the National Institute for Innovation in Manufacturing Biopharmaceuticals. It serves several key objectives:

  • Preparing students for jobs in the growing biopharmaceutical development field.
  • Broadening the number of skilled workers who can use advanced analytics tools to assist the biopharma industry utilize massive amounts of manufacturing data to identify problems, optimize performance, and ensure quality.
  • Creating off-the-shelf instruction for community college professors and others to introduce students to Python programming language, applications, and problem-solving techniques.

As the demand for skilled professionals in biomanufacturing surges, particularly in data-driven processing, the need for a workforce proficient in data analytics becomes increasingly critical.

Health Technology Insights: Solidsoft Reply Integrates Hellenic Medicines System into EMVS

The new BioCAD program will expand upon an existing biomanufacturing analytics curriculum currently used in four-year California colleges and the industry. The aim is to serve two audiences. First, it introduces students in the life sciences and bioprocessing to the tools and techniques essential for designing, producing, and delivering precision next-generation drugs. Participants will be better able to identify meaning in complex data, ask critical questions, solve problems, and make recommendations that improve quality and efficiency across the biopharma supply chain. Second, it introduces software engineering and data science students to compelling applications in biopharma that are rarely presented in college computer science and analytics courses.

SCU and BCI will implement an innovative program model that bridges traditional gaps between industry applications and academic programs. Expert teams at Genentech and Merck will help identify critical advanced analysis problems common to emerging cell and gene therapies, advise on the design and modularization of specific curricula, and support rigorous beta testing.

Parallel collaborations with community college instructors across California will support integration of instructional materials for use in community college courses. This ensures students at different educational levels are exposed to emerging roles in biotech and develop essential skills for successful life sciences careers.

Health Technology Insights: Sofinnova Partners and Gustave Roussy Launch Biotech Venture

“The BioCAD curriculum is designed to prepare students for a career in the biomanufacturing industry. By collaborating with community colleges, we aim to ensure access to this curriculum in a way that is sustainable and provides long-term benefits to students,” said Prashanth Asuri, Santa Clara University Chair and Professor of Bioengineering and Director of the Healthcare Innovation and Design Program.

Ultimately, the program is expected to help more than 500 students and 100 industry professionals annually gain skills in preparation for manufacturing, process development, analysis, and scientific jobs in biomanufacturing.

Training the Trainers

To achieve this, community college instructors from across the state will convene at Santa Clara University in mid-2025 to learn how to teach Python as it applies to biomanufacturing, providing input that will shape the development of new teaching and learning modules for community college classrooms. This will significantly expand the Biomanufacturing Consortium for Analytics and Data Engineering (BioCAD) training program, preparing it for broader dissemination benefiting students across California.

“Biocom California Institute is dedicated to workforce and talent development for the life sciences. BCI’s work on programs like BioCAD and others bridge the gap between the need for qualified professionals and the abundance of aspiring employees who require specific training or knowledge,” said Tim Scott, Biocom California CEO. “Under the leadership of Vicki Brannock, BCI has seen tremendous success in engaging students, companies, HR professionals, and other stakeholders to achieve this goal.”

Health Technology Insights: Ostial Corporation Becomes Verge Medical Following Strategic Acquisition

“To sustain the growth and innovation of the life science industry in California and nationwide, we need to cultivate a talented workforce,” said Vicki Brannock, Biocom California Institute Senior Director of Workforce Strategy and Innovation. “By partnering with the community colleges, we’re exponentially expanding the reach of a course currently exclusive to SCU, enabling it to benefit a much broader audience. This unique approach ensures that essential training is accessible to individuals from all educational backgrounds, amplifying its impact. This enhances employment opportunities and drives widespread innovation across the industry.”

This initiative is the latest in a series of successful collaborations between NIIMBL, Biocom California Institute, and Santa Clara University. Earlier this year, the NIIMBL eXperience program engaged a cohort of students to explore careers in biotechnology and biomanufacturing. Participants visited manufacturing sites, attended industry panels, and built valuable connections, sparking interest and providing pathways into the field.

This project was developed with an award from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and financial assistance from the U.S. Department of Commerce, National Institute of Standards and Technology

Health Technology Insights: New Resources Designed to Advance Commercial Success for Digital Health Technologies

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

Source – businesswire